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Although penicillin and other antitreponemal antibiotics have had a dramatic effect upon the prognosis of syphilitic disease, otological manifestations both early and late continue to be seen. Neonatal congenital syphilitic otolabyrinthitis and meningoneurolabyrinthitis are not encountered today, at least in Britain, presumably due to screening tests and appropriate therapy during pregnancy. These clinicopathological entities were The natural history has been described in detail.16 17 The deafness in late congenital syphilis is usually symmetrical while in late acquired disease it is often asymmetrical and may remain unilateral for months or years. The onset with tinnitus is sudden in 20% of cases and the symptoms fluctuate in 30%, especially the distortion and discrimination. Within the first two years of onset the pure tone hearing loss, as in Meniere's disease, is low or low plus high-tone. As deafness progresses the loss becomes high tone and finally subtotal to total. In the earlier stages specialised hearing tests localise the lesion in the cochlea and transtympanic electrocochleography confirms the presence of hydrops by demonstrating an enhanced negative summating potential generated from the distorted basilar membrane. Yaws due to T perpenue is transmitted by direct contact usually in childhood. The weeping skin lesions leave the typical paper-thin scars particularly on the lower limbs. With immigration from parts of Africa, Central America, the West Indies and SE Asia yaws is no longer a rare disease in Britain. The late otological manifestations are identical to those of late congenital syphilis and the treatment is the same.
In the pre-penicillin era, Moore'9 found that arsenicals had no effect in preventing advancing deafness in late congenital or acquired syphilis, though he did report temporary success in treating the sudden deafness due to early meningovascular disease. Though penicillin has become the treatment of choice for syphilis it has not solved the problems associated with late ear disease. There is now adequate clinical and pathological evidence to suggest that the established case will never be cured, though it may be arrested. Neonatal congenital syphilis treated adequately with penicillin does not prevent the onset of temporal bone gammatous disease in early adult life. Penicillin is usually given in high parenteral dosage with probenecid to block kidney excretion. Other antibiotics such as erythromycin, the tetracyclines, chloramphenicol, cephaloridine or the third generation cephalosporins are antitreponemal and may have to be considered if there is penicillin allergy, found in as many as 10% of patients with late syphilitic deafness'6 due to prior therapy. late yaws. The rationale of initial treatment with both steroids and antibiotics is that steroids might encourage spirochaete multiplication at which time they would be more susceptible to antibiotic damage. It is equally possible that organisms in the temporal bones have lost their pathogenicity but not their antigenicity and that the treatment results reflect local anti-inflammatory properties. These concepts have been examined. '6 17 Steroid treatment consists of prednisone 10 mg thrice daily for the first week, 25 mg daily for the next two weeks, and thereafter a maintenance dose of 2.5 to 7.5 mg daily for months or years. More recently the alternative has been dexamethasone 4 mg qds for the first week, 4 mg tds for the second and maintenance therapy of 0.5 to 1.5 mg daily. If there is no hearing response in the first three weeks, some consider withdrawal advisable but maintenance therapy can prevent further hearing loss even if there has been no apparent benefit from initial therapy. The disadvantages of long-term steroids have to be weighed against the benefits.
Hearing gains of 20-30 dB with improved discrimination can be expected provided the changes are not too advanced and the deafness history less than two years. Relapse rates following steroid withdrawal may be minimised by concomitant antibiotic therapy. Sudden deafness carries a poorer prognosis and a history of fluctuation a better one. Vestibular symptoms are dramatically controlled. Retreatment following relapse is rarely effective but patient control of maintenance therapy is desirable.
